It comes at a time when a number of HRT drugs are in severe short supply, meaning that even if women can pay for these ...

Non-stick pans are popular in kitchens around the world, promising ease of cooking and cleaning. However, more recent studies ...

Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...

Unlike short-lived fixes that merely accelerate metabolism for temporary effect, Lipozem takes a root-cause approach, ...

In today's world, many men are seeking effective solutions to enhance their performance and regain confidence. Whether it's the stress of daily life, the effects of aging, or simply a desire to ...

For some, Black hair is an expression of identity and culture. It’s a representation of history and carries a deep emotional ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO) has granted the nonproprietary name of ’emestedastat’ to Actinogen for its Xanamem ® /UE2343 once-a-day small ...

Even if our state did work to protect our farmland, as in Maine and Vermont, we New Yorkers are still drinking milk from other states and eating produce from other states. Cows that graze on land ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...